Interim report January – March 2025

On April 29, 2025 BioInvent reported its first quarter 2025 results (Presentation, BioInvent, APR 29, 2025, https://www.bioinvent.com/sites/bioinvent/files/pr/20250429-c64aa85c-d047-4e18-9e3d-bb005169a1cf-1.pdf?ts=1745906421 [SID1234654248]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!